AskBorsa

EIPICO

PHAR
Fiscal year starts in January · currency EGP · latest: Q2 2026
Next results: Q3 2026 — expected around 22 November 2026estimated from earlier disclosure datesResults calendar ←
98.40EGP+3.46% today1w +1.0%1m −16.1%delayed · 3 November
Net profit · 2024
1.1billion
▲ 33.2% vs 2023
Total assets · 2024
15.37billion
▲ 54.1% vs 2023
Shareholders' equity · 2024
4.66billion
▲ 9.3% vs 2023
Operating cash flow · 2024
−1.27billion
▼ 1510.5% vs 2023

Key facts

Source: annual statements 2024
  • EIPICO's net profit in 2024 was 1.1 billion EGP, up 33.2% from 823 million EGP in 2023.
  • Total assets at the end of 2024 were 15.37 billion EGP, and shareholders' equity 4.66 billion EGP.
  • Operating cash flow in 2024 was negative at 1.27 billion EGP.

EIPICO's Q3 2026 results are expected around 22 November — we email you the day they land

One email on the day, no account, and a one-click stop in the email itself.

orFollow on TelegramEvery result as it lands, in the @askborsa channel

By subscribing you agree to receive these alerts only. Privacy policy

AI summary

Preparing a summary of the latest results…

Annual net profit last 5 years
Net profit
423million
484million
587million
823million
1.1billion
20202021202220232024

Summarised financial statements

Excel · Pro
Swipe the table to see the other years.
Item · EGP20202021202220232024
Income statement
Net profit423 million484 million587 million823 million1.1 billion
Gross profit1.36 billion1.61 billion1.75 billion2.44 billion3.5 billion
Total assets5.03 billion5.27 billion6.77 billion9.98 billion15.37 billion
Total liabilities2.19 billion2.3 billion3.53 billion5.72 billion10.72 billion
Shareholders' equity2.85 billion2.97 billion3.24 billion4.26 billion4.66 billion
Total liabilities and equity5.03 billion5.27 billion6.77 billion9.98 billion15.37 billion
Operating cash flow165 million384 million-297 million90.35 million-1.27 billion
Investing cash flow-206 million-371 million-530 million-2.33 billion-2.68 billion
Financing cash flow197 million-427 million703 million2.21 billion406 million
Net change in cash155 million-415 million-123 million-29.46 million-99.9 million
Sign up free to see the full five years for every period.
Sign up free in seconds
With Google or your email, no password.

Figures in EGP from the published statement summaries (consolidated where the company publishes consolidated statements), after normalising reporting units across periods. The exact figure is in the attached report, which may be the standalone version. What does this line mean?

Results by period

One page per period: the figures against the same period a year earlier, and the official report.

Financial reports (20)

Other companies in Health Care & Pharmaceuticals

Ranked by latest annual net profit
All companies in the sector ←